跳至主要内容
临床试验/JPRN-UMIN000017838
JPRN-UMIN000017838已完成未知

The clinical study to assess the effect of the amount of carbohydrate intake and meals differing in glycemic index (GI) in patients treated with a sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor - The clinical study to assess the effect of the amount of carbohydrate intake and meals differing in glycemic index (GI) in patients treated with a sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor

Kansai Electric Power Hospital0 个研究点目标入组 24 人开始时间: 2015年6月9日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Patients who are diagnosed as diabetes mellitus other than type 2 diabetes, e.g., type 1 diabetes, diabetes with specific mechanism or disease except for type 2 diabetes, pregnancy diabetes (2) Patients with complication of severe kidney dysfunction, e.g., nephrotic syndrome, renal failure, dialytic therapy (3) Patients with eGFR < 45mL/min/1.73m2 at screening examination (4) Patients with complication of severe hepatic disorder, e.g., hepatocirrhosis (5) Patients with complication of severe heart disease, e.g., cardiac infarction, cardiac failure, or of cerebral infarction, or patients with medical history of those within 6 months prior to the initiation of the clinical study (obtaining informed consent) (6) Patients who have serious complication of gastrointestinal disorders or who underwent a surgical operation that is known to affect the absorption of a drug by digestive tract (7) Patients with diabetic microangiopathy, e.g., retinopathy of diabetes, diabetic neuropathy, or others which cannot be fully controlled regardless of continuing treatment (8) Patients who are susceptible to dehydration (Patients with extremely poorly-controlled glycemia) (9) Patients with complication of malignancy (Patients who recovered from malignancy are permitted to participate in the clinical study) (10) Patients with a history of hypersensitivity to Luseogliflozin (11) Patients who is a chronic heavy drinker (12) Female patients who are pregnant, possibly pregnant, or breast-feeding (13) Other patients who are judged as ineligible for enrollment in the clinical study by the principal investigator or subinvestigator

研究者

相似试验